Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Workflow Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Exosomes Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing adoption of exosome-based applications in diagnostics and therapeutics
3.2.1.2. Increasing investment in biomedical and translational research
3.2.1.3. Rising demand for liquid biopsy and non-invasive diagnostic technologies
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations pertaining to approval
3.2.2.2. Challenges associated with implementation of exosome-based therapies
3.2.2.3. High manufacturing and purification costs
3.3. Middle East Exosomes Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Middle East Exosomes Market: Product & Service Estimates & Trend Analysis
4.1. Product & Services Segment Dashboard
4.2. Middle East Exosomes Market Product & Service Movement Analysis
4.3. Middle East Exosomes Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Kits & reagents
4.4.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Instruments
4.5.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Services
4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Middle East Exosomes Market: Workflow Estimates & Trend Analysis
5.1. Workflow Segment Dashboard
5.2. Middle East Exosomes Market Workflow Movement Analysis
5.3. Middle East Exosomes Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
5.4. Isolation Methods
5.4.1. Isolation methods market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Ultracentrifugation
5.4.2.1. Ultracentrifugation market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3. Immunocapture on beads
5.4.3.1. Immunocapture on beads market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4. Precipitation
5.4.4.1. Precipitation market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5. Filtration
5.4.5.1. Filtration market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6. Others
5.4.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Downstream Analysis
5.5.1. Downstream analysis market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. Cell surface marker analysis using flow cytometry
5.5.2.1. Cell surface marker analysis using flow cytometry market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. Protein Analysis using blotting & ELISA
5.5.3.1. Protein Analysis using blotting & ELISA market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. RNA analysis with NGS & PCR
5.5.4.1. RNA analysis with NGS & PCR market estimates and forecasts 2021 to 2033 (USD Million)
5.5.5. Proteomic analysis using mass spectroscopy
5.5.5.1. Proteomic analysis using mass spectroscopy market estimates and forecasts 2021 to 2033 (USD Million)
5.5.6. Others
5.5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Middle East Exosomes Market: Application Estimates & Trend Analysis
6.1. Application Segment Dashboard
6.2. Middle East Exosomes Market Application Movement Analysis
6.3. Middle East Exosomes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Cancer
6.4.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Neurodegenerative Diseases
6.5.1. Neurodegenerative diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Cardiovascular Diseases
6.6.1. Cardiovascular diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Infectious Diseases
6.7.1. Infectious diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Others
6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Middle East Exosomes Market: End Use Estimates & Trend Analysis
7.1. End Use Segment Dashboard
7.2. Middle East Exosomes Market End Use Movement Analysis
7.3. Middle East Exosomes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Hospitals & Diagnostics Centers
7.5.1. Hospitals & diagnostics centers market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Academic & Research Institutes
7.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Middle East Exosomes Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Country Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. Middle East
8.4.1. Middle East Exosomes Market, 2021-2033 (USD Million)
8.4.2. Saudi Arabia
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Saudi Arabia Exosomes Market, 2021-2033 (USD Million)
8.4.3. UAE
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. UAE Exosomes Market, 2021-2033 (USD Million)
8.4.4. Kuwait
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Kuwait Exosomes Market, 2021-2033 (USD Million)
8.4.5. Qatar
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Qatar Exosomes Market, 2021-2033 (USD Million)
8.4.6. Oman
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Oman Exosomes Market, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Bio-Techne Corporation
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product/Service benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Danaher
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product/Service benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Hologic Inc.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product/Service benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Fujifilm Holdings Corporation
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product/Service benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Lonza
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product/Service benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Miltenyi Biotec
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product/Service benchmarking
9.4.6.4. Strategic initiatives
9.4.7. QIAGEN
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product/Service benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Thermo Fisher Scientific, Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product/Service benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Abcam Plc
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product/Service benchmarking
9.4.9.4. Strategic initiatives
9.4.10. RoosterBio, Inc.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product/Service benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Middle East exosomes market, by country, 2021-2033 (USD Million)
Table 4 Middle East exosomes market, by product & service, 2021-2033 (USD Million)
Table 5 Middle East exosomes market, by workflow, 2021-2033 (USD Million)
Table 6 Middle East exosomes market, by application, 2021-2033 (USD Million)
Table 7 Middle East exosomes market, by end use, 2021-2033 (USD Million)
Table 8 Saudi Arabia exosomes market, by product & service, 2021-2033 (USD Million)
Table 9 Saudi Arabia exosomes market, by workflow, 2021-2033 (USD Million)
Table 10 Saudi Arabia exosomes market, by application, 2021-2033 (USD Million)
Table 11 Saudi Arabia exosomes market, by end use, 2021-2033 (USD Million)
Table 12 UAE exosomes market, by product & service, 2021-2033 (USD Million)
Table 13 UAE exosomes market, by workflow, 2021-2033 (USD Million)
Table 14 UAE exosomes market, by application, 2021-2033 (USD Million)
Table 15 UAE exosomes market, by end use, 2021-2033 (USD Million)
Table 16 Kuwait exosomes market, by product & service, 2021-2033 (USD Million)
Table 17 Kuwait exosomes market, by workflow, 2021-2033 (USD Million)
Table 18 Kuwait exosomes market, by application, 2021-2033 (USD Million)
Table 19 Kuwait exosomes market, by end use, 2021-2033 (USD Million)
Table 20 Qatar exosomes market, by product & service, 2021-2033 (USD Million)
Table 21 Qatar exosomes market, by workflow, 2021-2033 (USD Million)
Table 22 Qatar exosomes market, by application, 2021-2033 (USD Million)
Table 23 Qatar exosomes market, by end use, 2021-2033 (USD Million)
Table 24 Oman exosomes market, by product & service, 2021-2033 (USD Million)
Table 25 Oman exosomes market, by workflow, 2021-2033 (USD Million)
Table 26 Oman exosomes market, by application, 2021-2033 (USD Million)
Table 27 Oman exosomes market, by end use, 2021-2033 (USD Million)
Table 28 Participant’s overview
Table 29 Financial performance
Table 30 Key companies undergoing acquisitions
Table 31 Key companies undergoing collaborations & partnerships
Table 32 Key companies launching new products/services
Table 33 Key companies undertaking other strategies
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Market segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Market driver impact
Figure 11 Market restraint impact
Figure 12 Porter’s analysis
Figure 13 PESTEL analysis
Figure 14 Middle East exosomes market: Product & service outlook and key takeaways
Figure 15 Middle East exosomes market: Product & service movement analysis
Figure 16 Middle East kits & reagents market, 2021-2033 (USD Million)
Figure 17 Middle East instruments market, 2021-2033 (USD Million)
Figure 18 Middle East services market, 2021-2033 (USD Million)
Figure 19 Middle East exosomes market: Workflow outlook and key takeaways
Figure 20 Middle East exosomes market: Workflow movement analysis
Figure 21 Middle East isolation methods market, 2021-2033 (USD Million)
Figure 22 Middle East ultracentrifugation market, 2021-2033 (USD Million)
Figure 23 Middle East immunocapture on beads market, 2021-2033 (USD Million)
Figure 24 Middle East precipitation market, 2021-2033 (USD Million)
Figure 25 Middle East filtration market, 2021-2033 (USD Million)
Figure 26 Middle East other isolation methods market, 2021-2033 (USD Million)
Figure 27 Middle East downstream analysis market, 2021-2033 (USD Million)
Figure 28 Middle East cell surface marker analysis using flow cytometry market, 2021-2033 (USD Million)
Figure 29 Middle East protein analysis using blotting & ELISA market, 2021-2033 (USD Million)
Figure 30 Middle East RNA analysis with NGS & PCR market, 2021-2033 (USD Million)
Figure 31 Middle East proteomic analysis using mass spectroscopy market, 2021-2033 (USD Million)
Figure 32 Middle East other downstream analysis market, 2021-2033 (USD Million)
Figure 33 Middle East exosomes market: Application outlook and key takeaways
Figure 34 Middle East exosomes market: Application movement analysis
Figure 35 Middle East cancer market, 2021-2033 (USD Million)
Figure 36 Middle East neurodegenerative diseases market, 2021-2033 (USD Million)
Figure 37 Middle East cardiovascular diseases market, 2021-2033 (USD Million)
Figure 38 Middle East infectious diseases market, 2021-2033 (USD Million)
Figure 39 Middle East other applications market, 2021-2033 (USD Million)
Figure 40 Middle East exosomes market: End Use outlook and key takeaways
Figure 41 Middle East exosomes market: End Use movement analysis
Figure 42 Middle East pharmaceutical & biotechnology companies market, 2021-2033 (USD Million)
Figure 43 Middle East hospitals & diagnostics centers market, 2021-2033 (USD Million)
Figure 44 Middle East academic & research institutes market, 2021-2033 (USD Million)
Figure 45 Middle East exosomes market: Regional outlook and key takeaways
Figure 46 Middle East exosomes market estimates and forecast, 2021-2033 (USD Million)
Figure 47 Saudi Arabia key country dynamics
Figure 48 Saudi Arabia exosomes market estimates and forecast, 2021-2033 (USD Million)
Figure 49 UAE key country dynamics
Figure 50 UAE exosomes market estimates and forecast, 2021-2033 (USD Million)
Figure 51 Kuwait key country dynamics
Figure 52 Kuwait exosomes market estimates and forecast, 2021-2033 (USD Million)
Figure 53 Qatar key country dynamics
Figure 54 Qatar exosomes market estimates and forecast, 2021-2033 (USD Million)
Figure 55 Oman key country dynamics
Figure 56 Oman exosomes market estimates and forecast, 2021-2033 (USD Million)
Figure 57 Market participant categorization
Figure 58 Middle East exosomes market position analysis, 2024
Figure 59 Strategy framework
